title: Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
abstract: Murine monoclonal antibody HRS-4 (Ab1), which defines the cell-bound and soluble CD30 antigen associated with Hodgkin's lymphoma, was used to generate monoclonal anti-idiotypic antibodies (Ab2) in syngeneic BALB/c mice. Murine monoclonal Ab2 14G9 and Ab2 9G10 directed against HRS-4 were shown to be anti-idiotypic Ab2 beta carrying the internal image of the CD30 antigen. These antibodies bound specifically to HRS-4 and effectively inhibited binding of HRS-4 to a CD30 antigen preparation at concentrations as low as 50 ng/ml. KLH-coupled Ab2 beta 14G9 and 9G10 induced in BALB/c mice and New Zealand white rabbits a specific polyclonal humoral response against the 120 kDa band of the CD30 antigen. Moreover, BALB/c mice immunized i.p. with KLH-coupled 14G9 and 9G10 exhibited a statistically significant (p less than 0.01) delayed-type hypersensitivity reaction against CD30 expressing Hodgkin-derived L540-cells. We conclude from these data that Ab2 beta 14G9 and 9G10, mimicking structures of the nominal CD30 antigen, are capable of inducing a CD30-specific T-cell- and B-cell-mediated immune response in mice and even across species barriers in rabbits. These CD30 anti-id antibodies may hold promise for use as vaccines against CD30-antigen-expressing lymphomas.
authors.affiliation: Klinik I für Innere Medizin der Universität zu Köln, D-5000 Cologne, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Pohl
authors.forename: C
authors.initials: C
authors.lastname: Renner
authors.forename: M
authors.initials: M
authors.lastname: Schwonzen
authors.forename: M
authors.initials: M
authors.lastname: Sieber
authors.forename: P
authors.initials: P
authors.lastname: Lorenz
authors.forename: M
authors.initials: M
authors.lastname: Pfreundschuh
authors.forename: V
authors.initials: V
authors.lastname: Diehl
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000302:isolation & purification; D000917:Antibody Formation; D000918:Antibody Specificity; D015703:Antigens, CD / Q000032:analysis / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology*; D015153:Blotting, Western; D002460:Cell Line; D004591:Electrophoresis, Polyacrylamide Gel; D006689:Hodgkin Disease / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007140:Immunoglobulin Fab Fragments / Q000276:immunology / Q000302:isolation & purification; D007136:Immunoglobulins / Q000276:immunology; D007150:Immunohistochemistry; D017730:Ki-1 Antigen; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D014066:Palatine Tonsil / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014612:Vaccines
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D007140:Immunoglobulin Fab Fragments; D007136:Immunoglobulins; D017730:Ki-1 Antigen; D014612:Vaccines